The Cord Wants a Higher Pressure Than His Lungs Can Take
A motorcyclist's cervical spinal cord injury calls for a blood pressure target held for days. His bruised lungs are the reason that target might cost him more than it protects.
A.F., a 27-year-old man, was riding home from his shift at a bike shop when a car ran a stop sign; he was helmeted, and the impact left him with a C5-6 fracture-dislocation and an incomplete cervical spinal cord injury, ASIA grade C, with partial motor and sensory function preserved below the level — real, meaningful residual function worth protecting rather than a complete injury with a fixed ceiling on recovery. His chest CT also showed bilateral pulmonary contusions, moderate in extent, currently manageable on the ventilator but a real vulnerability to whatever fluid and vasopressor burden the next several days bring. His unsupported MAP is 68, well below the 85-90mmHg range the 2013 AANS/CNS guideline recommends maintaining for seven days to protect spinal cord perfusion — a target this exact patient's two competing injuries put in direct tension with each other for the first time in his course.
The traditional MAP 85-90 target was never established by a randomized trial; it derives from smaller observational series and case reports linking higher perfusion pressure to better neurologic recovery, evidence real enough to have shaped a generation of practice but not strong enough to be treated as a fixed physiologic requirement for every patient regardless of what else is happening to them. AO Spine's 2024 updated guideline reflects that same uncertainty directly, moving toward individualized targets and shorter durations rather than a uniform 85-90 for seven days across all patients, a recommendation grounded in exactly the tradeoff his own chest injury illustrates: sustained vasopressor support to hold a fixed high MAP increases fluid shifts and pulmonary vascular pressure, a real risk to lungs already bruised and vulnerable to worsening into ARDS. His incomplete injury, with residual function still present, argues for taking the perfusion-pressure question seriously rather than abandoning it — but his contusions argue against treating 85-90 for a full week as a number to be defended at any hemodynamic cost.
One perfusion target, two organs with a stake in it
He has real, preserved function below the injury level — this is exactly the incomplete-injury patient the perfusion-pressure literature is most relevant to. I want to target the traditional 85-90 for the full week. I know the evidence behind that number is observational, not a randomized trial, but it's what's guided practice, and I don't want to under-treat the one factor we can actually modify.
I hear the recovery-potential argument, and I'm not dismissing it. But his lungs are bruised, and sustaining a MAP of 85-90 for seven days means seven days of vasopressor and often fluid support that raises pulmonary vascular pressure — a real, well-documented path into ARDS in exactly this kind of contusion. AO Spine's 2024 update moved toward individualized, often lower targets partly for this reason. I don't think defending 85-90 for a full week is the safer choice here just because it's the more established number.
Both of your targets are still population averages applied to one patient whose actual signal is sitting right in front of us — his exam. Titrate the vasopressor to the lowest MAP that holds his current motor and sensory findings stable, checked with frequent, structured exams rather than a fixed number on either side. If his exam starts to decline, raise the target; if it holds at a lower MAP, that's real evidence this particular cord doesn't need 85-90 to stay protected, and his lungs get the benefit of not paying for a number he may not require.
His exam remained stable at a MAP of 79, meaningfully below the traditional 85-90 target, and vasopressor support was titrated down accordingly. His pulmonary contusions did not progress, and oxygenation stayed adequate throughout the titration period.
The neurosurgeon's concern was not disproven — whether a higher sustained MAP would have improved his eventual neurologic recovery further is a question this individualized approach can't answer, since 85-90 was never actually tried. The team agreed the exam-based titration protected his lungs at a real, quantifiable benefit, while leaving the ceiling on his neurologic outcome genuinely uncertain either way.